Yan Zhang

Yan Zhang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Pharmaceutical Biology
Verified
Journal Article
Open access
JZJingjing Zhang
Jingjing Zhang
ZCZixuan Cai
Zixuan Cai
MYMin Yang
Min Yang
LTLijuan Tong
Lijuan Tong
YZYan Zhang
Yan Zhang
Context: Salvia miltiorrhiza Bge. (Labiatae) (SMB) is applied clinically for management of diabetic osteoporosis in China, and research results has suggested its potential action on renin–angiotensin system (RAS). Objective: This study screens and explores naturally occurring bioactive constituents from the root of SMB acting on renin activity and evaluates its osteoprotective efficacy in diabetic mice. Materials and methods: Human embryonic kidney (HEK) 293 cells, engineered to express human renin, were used as an in vitro model to identify bioactive compound, tanshinone IIA, inhibiting renin activity. The C57BL/6 mice (n = 10 in each group) with diabetes induced by streptozotocin (STZ) were intraperitoneally injected with tanshinone IIA (10 and 30 mg/kg). The mice without STZ treatment and the diabetic mice treated with aliskiren were used as non-diabetic control and positive control, respectively. Results: Tanshinone IIA was found to display inhibitory effects on renin activity of HEK-293 cells; moreover, it down-regulated protein expression of ANG II in human renin-expressed HEK-293 cells. Treatment of diabetic mice with tanshinone IIA with both doses could significantly decrease ANG II level in serum (from 16.56 ± 1.70 to 10.86 ± 0.68 and 9.14 ± 1.31 pg/mL) and reduce ANG II expression in bone, consequently improving trabecular bone mineral density and micro-structure of proximal tibial end and increasing trabecular bone area of distal femoral end in diabetic mice. Conclusions: This study revealed beneficial effects of tanshinone IIA on bone of diabetic mice, and potentially suggested the application of Salvia miltiorrhiza in the treatment of osteoporosis and drug development of tanshinone IIA as a renin inhibitor.

1 January 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XCXiang-Fan Chen
Xiang-Fan Chen
XLXiao-Li Li
Xiao-Li Li
MYMin Yang
Min Yang
YSYan Song
Yan Song
YZYan Zhang
Yan Zhang

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
WLWen-Xiong Li
Wen-Xiong Li
XQXian-Hui Qin
Xian-Hui Qin
CPChristina Chui-Wa Poon
Christina Chui-Wa Poon
MWMan Sau Wong
Man Sau Wong
RFRui Feng
Rui Feng
YZYan Zhang
Yan Zhang
The nutritional level of vitamin D may affect musculoskeletal health. We have reported that vitamin D is a pivotal protector against tissue injuries by suppressing local renin-angiotensin system (RAS). This study aimed to explore the role of vitamin D receptor (VDR) in the protection against muscle atrophy and the underlying mechanism. A cross-sectional study on participants (n = 1034) in Shanghai (China) was performed to analyze the association between vitamin D level and the risk of low muscle strength as well as to detect the circulating level of angiotensin II (Ang II). In animal studies, dexamethasone (Dex) was applied to induce muscle atrophy in wild-type (WT) and VDR-null mice, and the mice with the induction of muscle atrophy were treated with calcitriol for 10 days. The skeletal muscle cell line C2C12 and the muscle satellite cells were applied in in vitro studies. The increased risk of low muscle strength was correlated to a lower level of vitamin D (adjusted OR, 0.58) accompanied by an elevation in serum Ang II level. Ang II impaired the myogenic differentiation of C2C12 myoblasts as illustrated by the decrease in the area of myotubes and the down-regulation of myogenic factors (MHC & MyoD). The phenotype of muscle atrophy induced by Dex and Ang II was aggravated by VDR ablation in mice and in muscle satellite cells, respectively, and mediated by RAS and its downstream PI3K/Akt/FOXO1 signaling. Calcitriol treatment exhibited beneficial effects on muscle function as demonstrated by the increased weight-loaded swimming time, grip strength and fiber area, and improved fiber type composition via regulating ubiquitin ligases and their substrates MHC and MyoD through suppressing renin/Ang II axis. Taken together, VDR protects against skeletal muscle atrophy by suppressing RAS. Vitamin D could be a potential agent for the prevention and treatment of skeletal muscle atrophy.

1 July 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RFRui Feng
Rui Feng
MHMing‐Chao He
Ming‐Chao He
QLQiang Li
Qiang Li
XLXiao‐Qiang Liang
Xiao‐Qiang Liang
DTDe‐Zhi Tang
De‐Zhi Tang
YZYan Zhang
Yan Zhang

6 October 2015 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
YZYan Zhang
Yan Zhang
LWL. Wang
L. Wang
YSY. Song
Y. Song
XZX. Zhao
X. Zhao
MWMan Sau Wong
Man Sau Wong
WZW. Zhang
W. Zhang

17 October 2016 in Food & Function
Verified
Journal Article
Closed access
PDF file
GCGuang-Tong Chen
Guang-Tong Chen
MYMin Yang
Min Yang
BCBing-Bing Chen
Bing-Bing Chen
YSYan Song
Yan Song
WZWei Zhang
Wei Zhang
YZYan Zhang
Yan Zhang
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG), an active component from the functional and medicinal herb Polygonum multiflorum Thunb, has the capacity of blocking angiotensin II (ANG II) signaling, a pathway within the renin–angiotensin system (RAS) which plays a critical role in the development of diabetic nephropathy (DN), and blockade of the RAS is currently used for the treatment of DN. Here we investigated the beneficial effect of TSG therapy on renal damage in the streptozotocin (STZ)-induced diabetes model. The STZ-treated C57BL/6J diabetic mice developed progressive albuminuria and renal tubular interstitial fibrosis within 10 weeks, accompanied by increased production of ANG II, fibronection, TGF-β, CTGF, TNF-α, RANTES and MCP-1 and decreased expression of slit diaphragm proteins in the kidney. The treatment of the diabetic mice with a TSG ameliorated kidney mass increase prevented albuminuria, and reduced tubular interstitial fibrosis. The TSG treatment suppressed the induction of fibronection, CTGF, TGF-β, and MCP-1 and reversed the decline of slit diaphragm proteins Neph-1, ZO-1, and FAT-1. These were accompanied by blockade of renal renin and ANG II accumulation induced by hyperglycemia. These data demonstrated that the inhibition of the RAS with TSG effectively prevented renal injury in diabetic nephropathy.